Evidence map›Paper›PMID 40646521›Full record

ArticleBMC veterinary research2025

Metabolomics provides novel understanding of Melissa officinalis mechanism of action ensuring its calming effect on dogs.

Anne-Sophie Roy, Fatima Zohra Aberkane, Sekhou Cisse, Aurélie Guibert, Damien Richard, Marie Lerouzic, Sorphon Suor-Cherer, Séverine Boisard, David Guilet, Mohammed El Amine Benarbia Benarbia and 1 more

Abstract read
In one paragraph

Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Anne-Sophie Roy *Nutrition, PathoPhysiology and Pharmacology (NP3) Unit, 101 Rte de Gachet, Oniris, 44300, Nantes, France.
Fatima Zohra Aberkane *Nor-Feed SAS, 3 Rue Amedeo Avogadro, Beaucouzé, 49070, France. fatima.aberkane@norfeed.net.
Sekhou CisseNor-Feed SAS, 3 Rue Amedeo Avogadro, Beaucouzé, 49070, France.
Aurélie GuibertNutrition, PathoPhysiology and Pharmacology (NP3) Unit, 101 Rte de Gachet, Oniris, 44300, Nantes, France.
Damien RichardPharmacology and Biological Toxicology Unit, UMR-INSERM 1107, CHU Clermont Ferrand, 58 rue Montalembert, CLERMONT-FERRAND Cedex 1, 63003, France.
Marie LerouzicNutrition, PathoPhysiology and Pharmacology (NP3) Unit, 101 Rte de Gachet, Oniris, 44300, Nantes, France.
Sorphon Suor-ChererNor-Feed SAS, 3 Rue Amedeo Avogadro, Beaucouzé, 49070, France.
Séverine BoisardUniv Angers, SONAS, SFR QUASAV, Angers, F-49000, France.
David GuiletUniv Angers, SONAS, SFR QUASAV, Angers, F-49000, France.
Mohammed El Amine Benarbia BenarbiaNor-Feed SAS, 3 Rue Amedeo Avogadro, Beaucouzé, 49070, France.
Mohamed Yassine MallemNutrition, PathoPhysiology and Pharmacology (NP3) Unit, 101 Rte de Gachet, Oniris, 44300, Nantes, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundAnimal welfare encompasses both its physical and mental states. This latter could be altered by several psychological-related disorders including stress and anxiety. To address these issues, Melissa officinalis, a Lamiaceae plant, ensuring the anxiolytic-type effects, is widely used. In this study, the main aim was to explore the effect of a commercial hydro-alcoholic Melissa officinalis extract (MOE) and its major compound rosmarinic acid (RA) on dogs' behavior and metabolome. To do so, twenty healthy beagle dogs were randomly assigned to 4 dietary supplements (5 dogs/group): the first group received a placebo supplemented with maltodextrose (200 mg/kg), the second group was supplemented with MOE (200 mg/kg), the third group received RA at a dose of 10.6 mg/kg, and the fourth group was administered α-casozepine (AC) at a dose of 225 mg in capsule form. Dogs' behavior was monitored after 4 weeks of treatment using a standardized evaluation grid developed by Oniris. In addition, 4-hydroxybyturic acid (GHB) was quantified to study the effect of the supplementations on the metabolites of γ-aminobutyric acid (GABA) biosynthetic pathway. Moreover, the impact of all supplementations on dogs' metabolome was assessed using untargeted metabolomics at the end of the supplementation period.

resultsResults demonstrated significant differences between the mean behavioral score of placebo group (-3.4) compared to MOE (2.0), RA (1.4), and AC (0.8) groups. In addition, GHB measurement revealed a decrease in its quantity in all supplemented groups compared to the control. Moreover, untargeted metabolomics uncovered several metabolic pathways, that were impacted by MOE supplementation linked to lipids and bile acids metabolism. Furthermore, RA supplementation impacted fatty acids and lipids metabolism pathways while supplementation with AC affected pathways linked to lysine and sphingolipids metabolism.

conclusionsOur study demonstrated a calming effect of MOE on beagles and proposes a novel hypothesis that sheds new light on its potential mechanism of action. This study underlines metabolomics as an effective tool for gaining deep insights into the metabolic changes associated with supplementation.

Indexed as

Anti-Anxiety AgentsBehavior, AnimalMelissaPlant ExtractsAnimalsCinnamatesDepsidesDietary SupplementsDogsFemaleMaleMetabolomeMetabolomicsRosmarinic AcidAnti-Anxiety AgentsCinnamatesDepsidesPlant ExtractsRosmarinic AcidBehaviorDog’s welfareMelissa officinalisMetabolomics

Identifiers

PMID40646521
PMCPMC12247294

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.